SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

CARE revises rating of Sterling Biotech’s bank facilities

11 Jul 2011 Evaluate

Credit rating agency, CARE has revised ratings of Rs 500.99 crore long term bank facilities of Sterling Biotech to BB from BBB+. The rating agency has also revised rating of Rs 355 crore short term bank facilities of the company to A4 from A3+.

The revisions in the ratings take into account the weakened financial risk profile of the company on account of tight liquidity position as reflected by a fall in the current ratio and substantial elongation of the working capital cycle.

Sterling Biotech is the flagship company of the Sandesara group, promoted by Nitin Sandesara. It is mainly engaged in the production and sale of pharma-grade gelatine, Di-calcium Phosphate (DCP), a by-product of gelatine mainly used as poultry feed and Co-Enzyme Q10 (CoQ10), a dietary supplement used to boost the human immune system.

Peers
Company Name CMP
BASF India 4035.90
Tata Chemicals 782.10
SRF 2780.75
Pidilite Inds. 1476.15
Deepak Nitrite 1875.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×